Researchers have advanced sequencing technology and bioinformatics analysis so much over the last decade that every biomedical discipline has adopted some form of genomics medicine. Renal research is no exception; however, nephrology continues to be underrepresented in genomic research. Part of the reason for this neglect is the nature of kidney disease. Patients with renal disease are complex to work with, representing a higher risk than patients with other diseases in clinical studies.
In this white paper, we discuss how Frenova® Renal Research is directly addressing the deficiency of renal genomic information and promoting kidney disease studies. To understand how to attract research to the kidney space, Frenova engaged with academic, medical and industry researchers to learn what was missing: patient data.
